Terms: = Pancreatic cancer AND MLLT6, AF17, 4302, ENSG00000108292, P55198
3 results:
1. The potential markers of endocrine resistance among HR+ /HER2+ breast cancer patients.
Chen K; Quan J; Yang J; Chen Z
Clin Transl Oncol; 2020 Apr; 22(4):576-584. PubMed ID: 31209793
[TBL] [Abstract] [Full Text] [Related]
2. Molecular Pathways: The Balance between cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor-κB Signaling for cancer Treatment.
Zeligs KP; Neuman MK; Annunziata CM
Clin Cancer Res; 2016 Sep; 22(17):4302-8. PubMed ID: 27422962
[TBL] [Abstract] [Full Text] [Related]
3. Determination of acquisition frequency for intrafractional motion of pancreas in CyberKnife radiotherapy.
Zhang H; Zhao G; Djajaputra D; Xie Y
ScientificWorldJournal; 2014; 2014():408019. PubMed ID: 24959616
[TBL] [Abstract] [Full Text] [Related]
